ERBB2 and breast cancer: The research of Asano et al. showed that the pCR rate was significantly higher in the high CD8+/FOXP3+ TIL ratio (CFR) group, and high-CFR status was an independent predictor of a favorable prognosis for TNBC and HER2+ breast cancer [42].